BiotechTube

VDMN-21 Patch Low Dose + VDMN-21 Patch High Dose + Vehicle Patch

Phase 2Completed
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Verruca Vulgaris

Conditions

Verruca Vulgaris, Warts, Common Wart

Trial Timeline

Feb 28, 2023 → Feb 25, 2025

NCT ID
NCT05799157

About VDMN-21 Patch Low Dose + VDMN-21 Patch High Dose + Vehicle Patch

VDMN-21 Patch Low Dose + VDMN-21 Patch High Dose + Vehicle Patch is a phase 2 stage product being developed by Veradermics for Verruca Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT05799157. Target conditions include Verruca Vulgaris, Warts, Common Wart.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05799157Phase 2Completed

Other Products from Veradermics

VDPHL01 QD + Placebo + VDPHL01 BID + PlaceboPhase 3
72
VDPHL01 + PlaceboPhase 3
72
VDPHL01 + PlaceboPhase 2/3
60
VDPHL01Phase 2
47